Acrux (ACR) Short Interest
Acrux (ASX:ACR) had 0.21% of shares reported as short positions as of 2 Dec 2024, representing 611,822 shares. Acrux operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Acrux
Acrux Limited is a leading Australian company in the pharmaceutical industry, specializing in the development and commercialization of topical and transdermal drug delivery systems. These innovative solutions are aimed at enhancing the efficiency and effectiveness of drug administration through the skin. With strong ties to scientific research and robust market distribution channels, Acrux positions itself as a pioneer in the transdermal patch market.
Short position
Acrux (ASX:ACR) has 0.21% of its shares on issue reported as short positions as of 2 Dec 2024, or about 611,822 shares. Over the past 30 days that figure has risen 0.20 percentage points, and over 90 days it has risen 0.20 percentage points. Its highest recorded short interest was 15.57% in July 2014. ACR is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ACR intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Acrux
Latest ACR news
All newsAbout
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ACR
Start a research thread or post the first pulse update